This study identifies baclofen as a differential regulator of TLR3 and TLR4 signaling in glia and immune cells, and offers insight on the role of baclofen in regulating the innate immune response in cellular pathology associated with MS. The gene discussed is TLR3; the disease is myeloid sarcoma.